News and Trends 1 Oct 2025 Asthma study suggests lung scarring may be reversible Find out about this new study that suggest that the lung scarring that severe asthma can cause could be reversible. October 1, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2025 First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics? FDA approval for Stealth BioTherapeutics’ elamipretide has been a long time coming. What does this mean for other ultra-rare disease companies? September 29, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 24 Sep 2025 Resurrecting the dodo: an ethical dilemma or chance at restoring biodiversity? Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird. What are the ethical concerns? September 24, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2025 Paper mills are a network: scientific fraud growing rapidly A new study has uncovered a network of paper mills contributing towards scientific fraud and disinformation. September 22, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2025 GLP-1 drugs on WHO Essential Medicines List: what’s the impact? The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision. September 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2025 Budget blues: where are cell and gene therapies heading? The European Cell & Gene Therapy Summit 2025 was a hotspot for scientists and investors to discuss critical issues faced by the industry. September 17, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2025 Kriya Therapeutics has raised over $1.2 billion, but for what? Gene therapies have witnessed a decline in investor interest in recent times. Despite this, Kriya Therapeutics seems to be attracting funds in the space. September 10, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 9 Sep 2025 Top biotech deals in August 2025 Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small molecules. September 9, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2025 With Lykos CRL now public, FDA opens new era of accountability As the release of a CRL declining Lykos’ therapy generates a strong reaction from MAPS, delve into what this new transparency could change. September 8, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 18 Aug 2025 mRNA vaccine funding cuts: the impact on U.S. healthcare and biotech The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech? August 18, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 Aug 2025 Top biotech deals in July 2025 Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery. August 8, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2025 Fusion proteins attract funds and biopharma partnerships Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial success. August 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email